Independent Pharmacy Cooperative (IPC), a Group Purchasing Organisation (GPO) for independent pharmacies in the United States, announced on Sunday that it has signed a cooperation agreement with Legacy Pharmacy Group (LPG), the tristate area's largest GPO for independent pharmacies.
This strategic partnership aims to enhance the capabilities and offerings for both organisations, benefiting members and advancing independent pharmacy.
The partnership is intended to provide a streamlined supply chain, fast delivery and competitive pricing for essential medications and healthcare products.
IPC's government relations team will work in collaboration with LPG legislative advocacy to provide members with insights, legislative updates and additional advocacy efforts. Together, IPC and LPG will champion PBM reform, protect pharmacist provider status and defend patient access to cost effective medications at community pharmacies.
LPG members will be able to use IPC's comprehensive suite of pharmacy services, including operational and clinical programme expansion and support, contract and PSAO compliance assistance, and business development resources.
IPC's iCare+ platform provides LPG members with access to digital health services that include tele health, patient transport and discount prescriptions offering patients the opportunity for non-emergent medical care, transportation and prescription services.
LPG members have access to their own warehouse for use as a quality secondary wholesaler and will now also gain access to an extensive range of brand-name and generic drugs through the IPC Warehouse.
Kaiser Permanente reports study findings showing significant cost savings
Apotex receives Health Canada approval for a generic Ozempic equivalent
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules
Dexcel Pharma's Nintedanib Capsules approved for US launch
Upsher-Smith launches generic version of Ciprodex ear drop suspension
Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars
Breckenridge Pharmaceutical partners with sterile injectable manufacturer Maiva Pharma
Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market
Cipla launches generic liraglutide injection in the US
Arna Pharma signs MOU with Slate Run Pharmaceuticals
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)